ResearcherThe Cancer Institute HospitalActive in the last 2 years
Yu Takahashi
Matched on OpenAlex author ID A5121079324. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 12
2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper
Papers 2
- ASO Author Reflections: Beware the Collaterals: Vein Formation Signals Higher Surgical Risk in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1245/s10434-025-18960-9↗
- Serum DUPAN-2 could be an Alternative Biological Marker for CA19-9 Nonsecretors with Pancreatic Cancer. Last author DOI 10.1097/sla.0000000000005395↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yosuke Inoue · 2 shared papers, 2023–2026 · strength 0.46
- Paper ASO Author Reflections: Beware the Collaterals: Vein Formation Signals Higher Surgical Risk in Pancreatic Ductal Adenoc… DOI 10.1245/s10434-025-18960-9↗
- Paper Serum DUPAN-2 could be an Alternative Biological Marker for CA19-9 Nonsecretors with Pancreatic Cancer. DOI 10.1097/sla.0000000000005395↗
- Yoshihiro Ono · 2 shared papers, 2023–2026 · strength 0.46
- Paper ASO Author Reflections: Beware the Collaterals: Vein Formation Signals Higher Surgical Risk in Pancreatic Ductal Adenoc… DOI 10.1245/s10434-025-18960-9↗
- Paper Serum DUPAN-2 could be an Alternative Biological Marker for CA19-9 Nonsecretors with Pancreatic Cancer. DOI 10.1097/sla.0000000000005395↗
- Atsushi Oba · 2 shared papers, 2023–2026 · strength 0.46
- Paper ASO Author Reflections: Beware the Collaterals: Vein Formation Signals Higher Surgical Risk in Pancreatic Ductal Adenoc… DOI 10.1245/s10434-025-18960-9↗
- Paper Serum DUPAN-2 could be an Alternative Biological Marker for CA19-9 Nonsecretors with Pancreatic Cancer. DOI 10.1097/sla.0000000000005395↗
- Hiromichi Ito · 2 shared papers, 2023–2026 · strength 0.46
- Paper ASO Author Reflections: Beware the Collaterals: Vein Formation Signals Higher Surgical Risk in Pancreatic Ductal Adenoc… DOI 10.1245/s10434-025-18960-9↗
- Paper Serum DUPAN-2 could be an Alternative Biological Marker for CA19-9 Nonsecretors with Pancreatic Cancer. DOI 10.1097/sla.0000000000005395↗
- Tatsunori Miyata · 1 shared paper, 2026 · strength 0.30
- Masaaki Iwatsuki · 1 shared paper, 2026 · strength 0.30
- Y. H. Andrew Wu · 1 shared paper, 2023 · strength 0.16
- Takashi Sasaki · 1 shared paper, 2023 · strength 0.16
- Masato Ozaka · 1 shared paper, 2023 · strength 0.16
- Kojiro Omiya · 1 shared paper, 2023 · strength 0.16
- Akio Saiura · 1 shared paper, 2023 · strength 0.16
- Naoki Sasahira · 1 shared paper, 2023 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.